ISHPSB-L Archives

Intl Soc for the Hist Phil and Soc St of Biol

ISHPSB-L@LISTS.UMN.EDU

Options: Use Forum View

Use Monospaced Font
Show HTML Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Message-ID:
Sender:
Intl Soc for the Hist Phil and Soc St of Biol <[log in to unmask]>
Subject:
From:
Lucie Laplane <[log in to unmask]>
Date:
Fri, 13 Dec 2024 11:39:28 +0100
Content-Type:
multipart/alternative; boundary="000000000000a5446306292472b6"
MIME-Version:
1.0
Reply-To:
Lucie Laplane <[log in to unmask]>
Parts/Attachments:
text/plain (5 kB) , text/html (9 kB)
Dear ISHers,

Here are a few of announcements:
(1) Call for proposals for the 2025 David Hull Prize - deadline Feb 15th
2025
(2) PhilInBioMed Seminar - Aurora Nedelcu - Dec 16th
(3) Postdoctoral fellowship at the University of Cambridge - deadline Jan
12th 2025

Have a good day,
Lucie



*(1) Call for proposals for the 2025 David Hull Prize*

The David L. Hull Prize is a biennial prize established in 2011 by ISHPSSB
to honor the life and legacy of David L. Hull (1935–2010). It is awarded to
an individual who has made extraordinary contributions to scholarship and
service in ways that promote interdisciplinary connections between history,
philosophy, social studies, and biology and foster the careers of younger
scholars. These are strengths that reflect the contributions of David Hull
to our professions and to our Society.

Nominations for the Hull Prize are now open for consideration by the 2025
David Hull Prize Committee. The nomination packet should include the
following materials:

1. Nominator's name and email address,
2. nominee's name and email address,
3. a full CV of the nominee,
4. citation text (maximum of 1000 words),
5. and a minimum of two and a maximum of four letters of nomination, each
signed by at least one member of ISHPSSB.

Those who submitted nominations in the last recent past are encouraged to
resubmit an updated nomination packet.

Nomination packets should be sent as PDF attachments to the chair of the
2025 David Hull Prize Committee, Prof. Gregory Radick (
[log in to unmask]), with "Hull Prize" in the subject heading.
Nominations should be received no later than 15 February 2025. The Hull
Prize Committee will inform the nominator of the outcome of their decision
process in late March/early April.

Gregory Radick
Chair of the David L. Hull Prize Committee


*(2) PhilInBioMed Seminar*

*Aurora Nedelcu (University of New Brunswick, Canada)*
*"Cancer and the Evolution of Multicellularity: Limitations of Current
Views and Paradigms"*
*December 16th, 2024, 5pm (French time, UTC+1)*
*PhilInBioMed Seminar Series, organized by the University of Bordeaux,
France*

*Abstract*
The evolution of multicellularity requires the integration of single cells
into new functionally, reproductively and evolutionary stable multicellular
individuals. As part of this process, a change in levels of selection
occurs, with selection at the multicellular level overriding selection at
the cell level. The stability of multicellular individuals is dependent on
a combination of mechanisms that control within-group evolution, by both
reducing the occurrence of somatic mutations as well as supressing somatic
selection. Nevertheless, mutations that, in a particular microenvironment,
confer mutant cell lineages a fitness advantage relative to normal somatic
cells do occur, and can (but not always) result in cancer. This talk will
highlight several views and paradigms that relate the evolution of
multicellularity to cancer. Cancer is generally understood as a disease of
multicellularity, and is interpreted in different frameworks: (i) a
breakdown of cooperative behaviors (i.e., cheating) underlying the
evolution of multicellularity, (ii) a disruption of molecular networks
established during the emergence of multicellularity to impose constraints
on single-celled units, or (iii) an atavistic state resulting from
reactivating primitive programs that originated in the earliest unicellular
species. Several assumptions are common in all the views relating cancer as
a disease to the evolution of multicellularity. For instance, cancer is
considered a reversal to selfish unicellularity, and cancer cells are
thought to resemble unicellular organisms and benefit from ancestral-like
traits. I will discuss potential limitations of current views and paradigms
and show how different perspectives can provide novel insights with
potential therapeutic implications.

*Zoom link: please contact Thomas Pradeu <[log in to unmask]>*
*detailed information: *https://www.philinbiomed.org/event/aurora-nedelcu/

*(3) Postdoctoral fellowship at the University of Cambridge*

Jacob Stegenga' hiring message:
I'm hiring a postdoc, who will be based at the University of Cambridge
Leverhulme Centre for the Future of Intelligence, where I continue to have
an affiliation after my move to NTU Singapore. This postdoc position is
funded by a project grant held jointly with Stephan Hartmann at LMU Munich.
The deadline to apply is January 12, and the start date is flexible, though
the sooner the better. The position is funded for just about two years (the
awkward timing and duration is a result of my move to NTU, and we will do
our best to fill any potential employment gaps). We are looking for a
philosopher of science interested in causation, causal inference, evidence,
and expert judgement, particularly in the context of medicine, and we
welcome applicants using a diverse range of approaches in their research,
including formal methods, computer simulations, and case studies. The
postdoc will be part of a team based in Cambridge, Munich, and Singapore,
and the position includes funds for conference travel, workshops, and
visits to Munich. Please spread the word! And please let potential
candidates know that they can contact me with questions.

Best,
Jacob

Jacob Stegenga <https://sites.google.com/view/jacob-stegenga>

https://www.jobs.cam.ac.uk/job/49534/


ATOM RSS1 RSS2